original ) (raw )PET Monitoring of Therapy Response in Head and Neck Squamous Cell Carcinoma
Heiko Schoder
Journal of Nuclear Medicine, 2009
View PDFchevron_right
Evaluation of D-18F-FMT, 18F-FDG, L-11C-MET, and 18F-FLT for Monitoring the Response of Tumors to Radiotherapy in Mice
Hideo Tsukada
Journal of Nuclear Medicine, 2009
View PDFchevron_right
Repeatability of 18F-FDG uptake measurements in tumors: A metaanalysis
Harm van Tinteren
Journal of Nuclear Medicine, 2012
View PDFchevron_right
Consensus recommendations for the use of 18F-FDG PET as an indicator of therapeutic response in patients in National Cancer Institute Trials
Lalitha Shankar
Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2006
View PDFchevron_right
Enhanced Response of Human Head and Neck Cancer Xenograft Tumors to Cisplatin Combined With 2-Deoxy-d-Glucose Correlates With Increased 18F-FDG Uptake as Determined by PET Imaging
Andrean Simons , Douglas Spitz , Melissa Fath
International Journal of Radiation Oncology*Biology*Physics, 2007
View PDFchevron_right
The standardized uptake value of 2[18F] fluoro-2 deoxy-D-glucose in predicting outcome in head and neck carcinomas treated by radiotherapy with and without chemotherapy
Pavel Dulguerov
View PDFchevron_right
FDG-PET for prediction of tumour aggressiveness and response to intra-arterial chemotherapy and radiotherapy in head and neck cancer
Norihiro Sadato
European Journal of Nuclear Medicine and Molecular Imaging, 2003
View PDFchevron_right
Monitoring Response to Radiotherapy in Human Squamous Cell Cancer Bearing Nude Mice: Comparison of 2′-deoxy-2′-[18F]fluoro-d-glucose (FDG) and 3′-[18F]fluoro-3′-deoxythymidine (FLT)
Ben Slotman
Molecular Imaging and Biology, 2007
View PDFchevron_right
FDG–PET. A possible prognostic factor in head and neck cancer
Mark McGurk
British Journal of Cancer, 2002
View PDFchevron_right
Early response monitoring with 18F-FDG PET and cetuximab-F(ab')2-SPECT after radiotherapy of human head and neck squamous cell carcinomas in a mouse model
Otto Boerman
Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2014
View PDFchevron_right
Correspondence re: H. Barthel et al., 3'-deoxy-3'-[(18)F]fluorothymidine as a new marker for monitoring tumor response to antiproliferative therapy in vivo with positron emission tomography. Cancer Res., 63: 3791-3798, 2003
Aren van Waarde
Cancer research, 2003
View PDFchevron_right
Can 111In-RGD2 monitor response to therapy in head and neck tumor xenografts?
Otto Boerman
Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2014
View PDFchevron_right
Early metabolic 18F-FDG PET/CT response of locally advanced squamous-cell carcinoma of head and neck to induction chemotherapy: A prospective pilot study
Genival Barbosa De Carvalho
PLOS ONE
View PDFchevron_right
18F-Deoxyglucose (18F-FDG) Positron Emission Tomography/Computed Tomography (PET/CT) Monitoring of Dynamic Growth Characteristics of Walker-256 Tumor Models in 3 Different Locations in Rats
Xiuying Wang
Medical Science Monitor, 2019
View PDFchevron_right
FDG PET studies during treatment: Prediction of therapy outcome in head and neck squamous cell carcinoma
Sven-erik Strand
Head & Neck, 2002
View PDFchevron_right
Differential 18F-FDG and 3'-Deoxy-3'-18F-Fluorothymidine PET Responses to Pharmacologic Inhibition of the c-MET Receptor in Preclinical Tumor Models
Rodney Hicks
Journal of Nuclear Medicine, 2011
View PDFchevron_right
Evaluation of repeated [18F]EF5 PET/CT scans and tumor growth rate in experimental head and neck carcinomas
Heikki Minn
EJNMMI Research, 2014
View PDFchevron_right
Evaluation of 18F‐FDG PET/CT as an early imaging biomarker for response monitoring after radiochemotherapy using cetuximab in head and heck squamous cell carcinoma
Gabriela Studer
Head & neck, 2019
View PDFchevron_right
Reproducibility Study of [18 F] FPP (RGD) 2 Uptake In Murine Models of Human Tumor Xenografts
Patrick Wedgeworth
European Journal of …
View PDFchevron_right
Utility of 3'-[(18)F]fluoro-3'-deoxythymidine as a PET tracer to monitor response to gene therapy in a xenograft model of head and neck carcinoma
malabika sen
American Journal of Nuclear Medicine and Molecular Imaging, 2013
View PDFchevron_right
Preclinical and Clinical Evidence that Deoxy-2-[18F]fluoro-D-glucose Positron Emission Tomography with Computed Tomography Is a Reliable Tool for the Detection of Early Molecular Responses to Erlotinib in Head and Neck Cancer
Olivier CASELLES
Clinical Cancer Research, 2010
View PDFchevron_right
Added value of baseline^{18} F-FDG uptake in serial^{18} F-FDG PET for evaluation of response of solid extracerebral tumors to systemic cytotoxic neoadjuvant …
Harm van Tinteren
2010
View PDFchevron_right
Reproducibility of18 F-FDG PET uptake measurements in head and neck squamous cell carcinoma on both PET/CT and PET/MR
Lena Specht
British Journal of Radiology, 2015
View PDFchevron_right
Simplified kinetic analysis of tumor 18F-FDG uptake: a dynamic approach
Nanette Freedman
Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2004
View PDFchevron_right
Kinetic Analysis of 3'-Deoxy-3'-18F-Fluorothymidine (18F-FLT) in Head and Neck Cancer Patients Before and Early After Initiation of Chemoradiation Therapy
John Sunderland
Journal of Nuclear Medicine, 2009
View PDFchevron_right
Rapid Reduction of 1-Receptor Binding and 18F-FDG Uptake in Rat Gliomas After In Vivo Treatment with Doxorubicin
Aren van Waarde
Journal of Nuclear Medicine, 2007
View PDFchevron_right
Stability of 3′-Deoxy-3′-[ 18 F]Fluorothymidine Standardized Uptake Values in Head and Neck Cancer Over Time
John Sunderland
Cancer Biotherapy & Radiopharmaceuticals, 2010
View PDFchevron_right
Effects of Intratumoral Inflammatory Process on 18 F-FDG Uptake: Pathologic and Comparative Study with 18 F-Fluoro-α-Methyltyrosine PET/CT in Oral Squamous Cell Carcinoma
Yoshito Tsushima
The Journal of Nuclear Medicine, 2014
View PDFchevron_right
Volume-of-Interest Assessment of Oncologic Response Using 18F-FDG PET/CT: A Phantom Study
Enrique Estrada Lobato
Journal of Nuclear Medicine Technology, 2011
View PDFchevron_right